Patents by Inventor Anna Gosiewska

Anna Gosiewska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000554
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: May 11, 2021
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Ian R. Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Patent number: 10791730
    Abstract: This invention provides for compositions for cryopreservation of human umbilical cord tissue-derived cells. The cryopreservation compositions may comprise: (a) amino acids; (b) vitamins; (c) inorganic salts; and (d) DMSO, sucrose, mannitol, and lactobionic acid. The invention also provides for kits comprising the composition and human umbilical cord tissue-derived cells and methods of cryopreserving the cells, which utilize the compositions.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: October 6, 2020
    Assignee: DEPUY SYNTHES PRODUCTS, INC.
    Inventors: Anna Gosiewska, Anthony J. Kihm
  • Patent number: 10758576
    Abstract: Cells derived from postpartum tissue and products thereof having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: September 1, 2020
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Laura J. Brown, Alexander M. Harmon, Anna Gosiewska
  • Publication number: 20200265937
    Abstract: Use of an artificial intelligence engine to provide skin care treatment is disclosed.
    Type: Application
    Filed: February 19, 2020
    Publication date: August 20, 2020
    Inventors: Anuli Anyanwu-Ofili, Khalid Mahmood, Nikoleta Batchvarova, Robert Boland, Anna Gosiewska, Antonius P.J. van den Heuvel, Gabriela Ona Cula
  • Patent number: 10603408
    Abstract: A biocompatible tissue repair implant or scaffold device is provided for use in repairing a variety of tissue injuries, particularly injuries to cartilage, ligaments, tendons, and nerves. The repair procedures may be conducted with implants that contain a biological component that assists in healing or tissue repair. The biocompatible tissue repair implants include a biocompatible scaffold and particles of living tissue, such that the tissue and the scaffold become associated. The particles of living tissue contain one or more viable cells that can migrate from the tissue and populate the scaffold.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: March 31, 2020
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Francois Binette, Julia Hwang, Sridevi Dhanaraj, Anna Gosiewska
  • Patent number: 10557116
    Abstract: Compositions and methods of using cells derived from umbilical cord tissue to stimulate and support lung tissue angiogenesis, to improve blood flow to lung tissue, to regenerate, repair, and improve lung tissue damaged by lung disease, disorder and/or injury, and to protect lung tissue from damage caused by lung disease, disorder and/or injury in a patient.
    Type: Grant
    Filed: December 19, 2009
    Date of Patent: February 11, 2020
    Assignee: DePuy Synthes Products, Inc.
    Inventors: David C. Colter, Anthony J. Kihm, Christine K. Ward, Anna Gosiewska
  • Patent number: 10500230
    Abstract: Isolated or purified mammalian kidney-derived cell populations from mammalian kidney tissue are provided. Methods are provided for the isolation and purification of the mammalian kidney-derived cell population. Methods for treating kidney disease are provided by administration of the isolated or purified mammalian kidney-derived cell population to a mammalian subject.
    Type: Grant
    Filed: October 11, 2007
    Date of Patent: December 10, 2019
    Assignee: DePuy Synthes Products, Inc.
    Inventors: David C. Colter, Agnieszka Seyda, Charito S. Buensuceso, Anna Gosiewska
  • Patent number: 10500234
    Abstract: Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: December 10, 2019
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Sanjay Mistry, Anthony J. Kihm, Ian R. Harris, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Patent number: 10413571
    Abstract: Isolated or purified mammalian kidney-derived cell populations from mammalian kidney tissue are provided. Methods are provided for the isolation and purification of the mammalian kidney-derived cell population. Methods for treating kidney disease are provided by administration of the isolated or purified mammalian kidney-derived cell population to a mammalian subject.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: September 17, 2019
    Assignee: DePuy Synthes Products, Inc.
    Inventors: David C. Colter, Agnieszka Seyda, Charito S. Buensuceso, Anna Gosiewska
  • Patent number: 10383898
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: August 20, 2019
    Assignee: Depuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Ian Ross Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20190192577
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 27, 2019
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Ian R. Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20190105352
    Abstract: Methods for treating a patient having a disease or condition related to IVD degeneration are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells. In some embodiments, administering the cells promotes repair and regeneration of degenerated IVD tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Application
    Filed: November 21, 2016
    Publication date: April 11, 2019
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Laura J. Brown, Anna Gosiewska, Anthony J. Kihm, Brian C. Kramer
  • Patent number: 10220059
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: March 5, 2019
    Assignee: DEPUY SYNTHES PRODUCTS, INC.
    Inventors: Anthony J. Kihm, Ian Ross Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Patent number: 10195233
    Abstract: Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions of the placenta-derived cells. The placenta-derived cells of the invention have a plethora of uses, including but not limited to research, diagnostic, and therapeutic applications.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: February 5, 2019
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Ian Ross Harris, Sanjay Mistry, Alexander M. Harmon, Darin J. Messina, Agnieszka Seyda, Chin-Feng Yi, Anna Gosiewska
  • Publication number: 20180344900
    Abstract: Methods for treating a patient having a disease or condition related to IVD degeneration are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells and optionally a hydrogel. In some embodiments, administering the cells promotes repair and regeneration of degenerated IVD tissue in the patient. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Application
    Filed: November 21, 2016
    Publication date: December 6, 2018
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Laura J. Brown, Anna Gosiewska, Anthony J. Kihm, Brian C. Kramer
  • Publication number: 20180338999
    Abstract: Cells derived from postpartum tissue and products thereof having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.
    Type: Application
    Filed: August 6, 2018
    Publication date: November 29, 2018
    Applicant: DePuy Synthes Products, Inc.
    Inventors: Laura J. Brown, Alexander M. Harmon, Anna Gosiewska
  • Patent number: 10039793
    Abstract: Cells derived from postpartum tissue and products thereof having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: August 7, 2018
    Assignee: DEPUY SYNTHES PRODUCTS, INC.
    Inventors: Laura J. Brown, Alexander M. Harmon, Anna Gosiewska
  • Patent number: 10022448
    Abstract: A composition comprising: a benefit agent; at least one polymer including a polycaprolactone polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent is disclosed.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: July 17, 2018
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Ying Sun, Anna Gosiewska, Dennis D. Jamiolkowski, Jeffrey M. Wu
  • Patent number: 9943552
    Abstract: Methods for treating Alzheimer's disease, or the symptoms of Alzheimer's disease, are provided. Some embodiments are to methods for treatment comprising administering cells obtained from human umbilical cord tissue, or administering pharmaceutical compositions comprising such cells or prepared from such cells, such as cell derivatives. Some embodiments are to methods for treatment comprising hUTC. Pharmaceutical compositions for use in the inventive methods, as well as kits for practicing the methods are also provided.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: April 17, 2018
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Anthony J. Kihm, Anna Gosiewska
  • Publication number: 20170360941
    Abstract: A composition comprising: a benefit agent; at least one polymer including a polycaprolactone polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent is disclosed.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 21, 2017
    Inventors: Ying Sun, Anna Gosiewska, Dennis D. Jamiolkowski, Jeffrey M. Wu